ACMG/AMP variant classification specifications from the ClinGen Epilepsy Sodium Channel Variant Curation Expert Panel

ClinGen Epilepsy Sodium Channel VCEP specifications, gene-specific adaptation of ACMG/AMP criteria, improved inter-laboratory concordance

The ClinGen Epilepsy Sodium Channel VCEP publishes adapted ACMG/AMP variant classification specifications for SCN1A, SCN2A, SCN3A, SCN8A, and SCN1B. Criteria are tailored for each gene by integrating gene-specific clinical, bioinformatic, and functional data. A pilot on 37 variants demonstrates significant improvement in inter-laboratory concordance compared to generic criteria, notably reducing discordant results on VUS.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

ClinGen VCEP specifications reduce classification heterogeneity between laboratories for high-stakes diagnostic genes like SCN1A (Dravet syndrome). Publication in Genet Med provides a reference for laboratories that have not yet adapted their internal criteria and directly contributes to harmonizing genetic diagnosis of epilepsy.

Clinical impact: 3/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 0/1 · Publication status: 1/1 → Total: 7/10